Apontis Pharma AG (APPH.DE) Stock Price

€11.4 0.4%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    5

  • Fundamental

    6

  • Technical

    6

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Apontis Pharma AG, AI stock picks, stock alerts and much more.

Sign up

APPH.DE AI Stock Analysis

AI stock analysis for APPH.DE is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Apontis Pharma AG (APPH.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Apontis Pharma AG (APPH.DE) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Apontis Pharma AG (APPH.DE), currently trading at €11.4, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About APPH.DE

LSE

  • Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany.

  • Symbol

    APPH.DE

  • Market

    XETRA

  • Industry

    Drug Manufacturers - Specialty & Generic

  • Market Cap

    95M

Similar Stocks

SBX.DE SynBiotic SE
SBX.DE		 €3.54
1.4%
4
PSG.DE PharmaSGP Holding SE
PSG.DE		 €24.6
0.00%
8
93M1.DE MPH Health Care AG
93M1.DE		 €23
0.9%
5
EVT.DE Evotec SE
EVT.DE		 €6.65
2.6%
3
ZOE.DE Zoetis Inc.
ZOE.DE		 €149.5
0.7%
5

News

Zentiva proposes EUR 10 per share offer for APONTIS PHARMA

Zentiva proposes EUR 10 per share offer for APONTIS PHARMA
October 16, 2024. Investing.com

APPH.DE Alternative Data

Web Traffic

Apontis Pharma AG receives an estimated 1134 monthly visitors to apontis-pharma.de.

  • Web Traffic

    1134

  • Change from Previous Month

    35.5%

  • 3 Month Change

    45.6%

  • YoY Change

    45.6%

News Mentions

Apontis Pharma AG was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

956 are following Apontis Pharma AG on LinkedIn, up by 1.7% over the last month.

  • LinkedIn Followers

    956

  • Daily Change

    0%

  • 1 Month Change

    1.7%

  • 3 Month Change

    11.6%

Job Postings

Apontis Pharma AG currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

Reddit Mentions

Apontis Pharma AG has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

LinkedIn Employees

According to LinkedIn, Apontis Pharma AG has 84 employees, down by -3.4% over the last month.

  • LinkedIn Employees

    84

  • Daily Change

    0%

  • 1 Month Change

    3.4%

  • 3 Month Change

    2.3%

APPH.DE Financials

APPH.DE Key Metrics

  • Total Revenue

    €22.7M

  • Net Income

    €702.8K

  • Earnings per Share

    €0.0844

  • Free cash flow

    -€4.5M

  • EBITDA

    €1.9M

  • EBITDA Ratio

    0.0824217

  • Total Assets

    €48.2M

APPH.DE 2-year Revenue & Income
APPH.DE 2-year Free Cash Flow

APPH.DE Technicals

APPH.DE SMA
APPH.DE RSI

FAQ

What's the current price of Apontis Pharma AG (APPH.DE) Stock?
The price of an Apontis Pharma AG (APPH.DE) share is €11.4.

What's the market cap of Apontis Pharma AG?
The current market cap of Apontis Pharma AG is 95M.

Should I buy or sell APPH.DE?
Apontis Pharma AG shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Apontis Pharma AG is better viewed as a hold or accumulate position while waiting for further developments.

Is Apontis Pharma AG a good investment?
The current analysis of Apontis Pharma AG's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Apontis Pharma AG's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Apontis Pharma AG (APPH.DE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Apontis Pharma AG stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Apontis Pharma AG (APPH.DE) that investors often compare it to?
Apontis Pharma AG (APPH.DE) is often compared to similar stocks such as SynBiotic SE, PharmaSGP Holding SE, MPH Health Care AG, Evotec SE and Zoetis Inc..

What is the forecast for Apontis Pharma AG's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Apontis Pharma AG's stock price to be around €11.72 in 2026. Starting from the current price of €11.4, this represents a 2.8% change in price, indicating a neutral outlook for the stock.

How to buy Apontis Pharma AG (APPH.DE) Stock?
Apontis Pharma AG stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Apontis Pharma AG shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.